In January, the Patent Trial and Appeal Board issued 43 IPR, CBM, and PGR Final Written Decisions including decisions following remands from the Federal Circuit, cancelling 509 (78.07%) instituted claims while upholding the patentability of 140 (21.47%) instituted claims. Patent owners conceded 3 (0.46%) instituted claims through motions to amend or disclaimer in cases reaching a final decision. For comparison, the cumulative average rate of instituted claims cancelled in IPR, CBM, and PGR Final Written Decisions is about 73%.

1179498a.jpg

On a per-case basis, no instituted or substitute claims survived in 25 (58.14%) decisions, all instituted claims survived in 3 (6.98%) decisions, and a mixed outcome occurred in 15 (34.88%) decisions. A mixed outcome occurs where at least one instituted or substitute claim remains patentable, and at least one is cancelled, in a Final Written Decision. 

1179498b.jpg

In February, the PTAB issued 42 IPR, CBM, and PGR Final Written Decisions, cancelling 555 (74.50%) instituted claims while upholding the patentability of 181 (24.30%) instituted claims. Patent owners conceded 9 (1.21%) claims through motions to amend or disclaimer in cases reaching a final decision. 

1179498c.jpg

On a per-case basis, no instituted or substitute claims survived in 25 (59.52%) decisions, all instituted claims survived in 7 (16.67%) decisions, and a mixed outcome occurred in 10 (23.81%) decisions. 

1179498d.jpg

The overall cumulative instituted claim survival rate in IPRs, CBMs, and PGRs, broken down by technology center, is as follows:

1179498e.jpg

More detailed cumulative statistics on the Board's IPR, CBM, and PGR decisions, updated through February 28, 2022, are available here on the At the PTAB Blog. 

Statistics regarding the outcome of appeals to the Federal Circuit are available here.

Numbers of final written decisions by technology center and instituted claim survival rates by technology center are available here

Various other PTAB metrics collected and generated by Finnegan are reserved for the use of Finnegan and its clients. Stay tuned to the At the PTAB Blog for the latest updates, analysis, and statistics on all aspects of PTAB and Federal Circuit practice.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.